COMMUNIQUÉS West-GlobeNewswire

Best SARMs For Muscle Growth: Cutting, Fat Loss, SARMs Before and After, SARMs Steroids, Are SARMs Legal, How to Get SARMs, What Does SARMs Stand For, Strongest SARMs (By Crazybulk)

01/05/2025 - 17:19

New York City, May 01, 2025 (GLOBE NEWSWIRE) -- NEW YORK, May 1, 2025: Selective Androgen Receptor Modulators (SARMs): A New Way to Build Muscle SARMs are special compounds that many people call “legal and safe anabolic [...]

Best SARMs For Fat Loss: Bulking, Cutting, What Are SARMs SARMs Bodybuilding, What Is a SARM, How To Take SARMs, What Is The Strongest SARM, Prohormones vs SARMs (By Crazybulk)

01/05/2025 - 17:25

New York City, May 01, 2025 (GLOBE NEWSWIRE) -- NEW YORK, May 1, 2025 Introduction The world of fitness and bodybuilding is always changing, and one exciting new development is something called Selective Androgen [...]

Load Boost: Semenax, Volume Pills or SemEnhance - Which is Best Load Boost Supplements of 2025?

01/05/2025 - 17:36

LAS VEGAS, May 01, 2025 (GLOBE NEWSWIRE) -- In 2025, men across the USA are increasingly turning to load boost supplements for better performance, enhanced pleasure, and improved reproductive health . Among the most [...]

Bathmate Under Review: Should You Buy Bathmate Pump? Read Before & After Bathmate Hydromax Results!

01/05/2025 - 18:15

Achieve permanent gains in size, strength, and confidence with the Bathmate Hydromax Penis Pump. Safe, easy-to-use, and water-based for maximum comfort. Start seeing real results in just weeks — no pills, no surgery, [...]

D-Bal MAX Under Review: Is D-Bal Max Legal & Safe? Best Dianabol Steroid Alternative To Build Muscle Fast

01/05/2025 - 18:25

Discover the truth in this in-depth D-Bal MAX review. Learn if D-Bal Max pills are legal, safe, and the best natural alternative to Dianabol steroids for rapid muscle growth and strength. Glasgow, May 01, 2025 (GLOBE [...]

3 Best Testosterone Supplements for Men to Gain Muscle OTC in 2025 - Buy Testosterone Boosters for Men Over 40 for Muscle Growth - Wolfson Brands

01/05/2025 - 18:48

Glasgow, May 01, 2025 (GLOBE NEWSWIRE) -- The 3 best testosterone booster supplements for muscle growth are presented by Wolfson Brands. The most compelling reasons men turn to testosterone supplements are to build [...]

HNL Lab Medicine Announces 4th Annual Children’s Art Contest

01/05/2025 - 18:49

ALLENTOWN, Pa., May 01, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine invites local artists in grades K–8 to enter its Annual Art Contest by May 31, 2025, for a chance to win a one-year membership to the Da Vinci Science [...]

Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians

01/05/2025 - 14:00

Neurogen’s Brain Health Care Ecosystem Accelerates Access to Early Detection Technology for Alzheimer’s dementia and Mild Cognitive Impairment CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking announced it [...]

electroCore’s Truvaga™ Now Works with the Apple Health app

01/05/2025 - 14:00

ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now [...]

Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights

01/05/2025 - 14:00

Akebia to Host Conference Call on May 8, 2025, at 8:00 a.m. EDT CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the [...]

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

01/05/2025 - 14:00

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced [...]

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

01/05/2025 - 14:00

SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 [...]

Rezolute to Participate in Upcoming Investor Conferences

01/05/2025 - 14:00

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with [...]

Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference

01/05/2025 - 14:00

SAN FRANCISCO and BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will present at the Bank of America Health Care Conference on Tuesday, May [...]

UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting

01/05/2025 - 14:00

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today [...]

Spur Therapeutics to Participate in Citizens JMP 2025 Life Sciences Conference

01/05/2025 - 14:00

LONDON, May 01, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that Chief Executive Officer Michael Parini will present a corporate overview at the Citizens JMP 2025 Life Sciences Conference being held May 7 [...]

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

01/05/2025 - 14:00

SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today [...]

4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME

01/05/2025 - 14:00

EMERYVILLE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]

Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right

01/05/2025 - 14:30

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and other diseases [...]